Genetic variants in PPARGC1B and CNTN4 are associated with thromboxane A2 formation and with cardiovascular event free survival in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). (2018)
Attributed to:
Large-scale integrative studies of risk factors in coronary heart disease: from discovery to application
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.atherosclerosis.2017.12.013
PubMed Identifier: 29258006
Publication URI: http://europepmc.org/abstract/MED/29258006
Type: Journal Article/Review
Volume: 269
Parent Publication: Atherosclerosis
ISSN: 0021-9150